bf/NASDAQ:BNTX_icon.jpeg

NASDAQ:BNTX

BioNTech SE

  • Stock

102.43

โˆ’1.65%

โˆ’9.23

USD last updated 11/08 02:03:55

Last Close

111.66

08/08 20:00

Market Cap

19.33B

Beta: 0.22

Volume Today

972.28K

Avg: 618.15K

PE Ratio

7.56

PFCF: 4.40

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ hea...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    510152018-03-302019-06-302020-12-312022-05-092024-03-252025-05-16

    Revenue (Estimate*)

    1B2B3B4B5B6B2018-03-302019-06-302020-12-312022-05-092024-03-252025-05-16

    *Estimate based on analyst consensus